Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis

Journal of Hepatology

Volumn 38, Issue 6, 2003, Pages 866-869

  Leroy Matheron, Catherine ^a   Duvoux, Christophe ^a   Van Nhieu, Jeanne Tran ^a   Leroy, Karen ^a   Cherqui, Daniel ^a   Gouault Heilmann, Michèle ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Activated protein C resistance; FV Leiden; Liver transplantation

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CORTICOSTEROID; ENOXAPARIN; FLUINDIONE; METHYLPREDNISOLONE; PROTEIN C; TACROLIMUS; TINZAPARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; DEEP VEIN THROMBOSIS; GENE MUTATION; GRAFT REJECTION; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; SCREENING;

EID: 0037564126     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00054-0     Document Type: Article

References (30)

1. Dalhbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-1008.
2. Koster T, Rosendaal F, de Ronde H, Briët E, Vandenbroucke J, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden thrombophilia study. Lancet 1993;342:1503-1506.
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
4. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82:1989-1993.
5. Bertina RM, Koelman BP, Koster T, Rosendaal FR, Dirven DJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
6. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and factor Va by activated protein C. J Biol Chem 1994;269:31869-31880.
7. Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterisation of the molecular defect in factor V R506Q. J Biol Chem 1995;270:4053-4057.
8. Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997;90:1552-1557.
9. Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, et al. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 1999;81:193-197.
10. Faioni EM, Franchi F, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, et al. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden). Blood 1999;94:3062-3066.
11. Wilson DB, Salem HH, Mruk JS, Maruyama I, Majerus PW. Biosynthesis of coagulation factor V by a human hepatocellular carcinoma cell line. J Clin Invest 1984;73:654-658.
12. Mazzorana M, Baffet G, Kneip B, Launois B, Guguen-Guillouzo C. Expression of coagulation factor V gene by normal adult hepatocytes in primary culture. Br J Haematol 1991;78:229-235.
13. Chiu HC, Schick P, Colman R. Biosynthesis of factor V in isolated guinea pig megakaryocytes. J Clin Invest 1985;75:339-346.
14. Gewirtz AM, Keefer M, Doshi K, Annamalai AE, Chiu HC, Colman RW. Biology of human megakaryocyte factor V. Blood 1986;67:1639-1648.
15. Gewirtz AM, Shapiro C, Shen YM, Boyd R, Colman RW. Cellular and molecular regulation of factor V expression in human megakaryocytes. J Cell Physiol 1992;153:277-287.
16. Camire RM, Pollak ES, Kaushansky K, Tracy PB. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998;92:3035-3041.
17. Cherqui D, Lauzet JY, Rotman N, Duvoux C, Dhumeaux D, Julien M, et al. Orthotopic liver transplantation with preservation of the caval and portal flows. Technique and results in 62 cases. Transplantation 1994;58:793-796.
18. Bell G, Karam J, Rutter W. Polymorphic region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 1891;78:5759-5763.
19. Diss T, Pan H, Wotherspoon AG, Isaacson PG. Sources of DNA for detecting B cell monoclonality using PCR. J Clin Pathol 1994;47:493-496.
20. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg 506 Gln mutation. Blood Coagul Fibrinolysis 1995;6:245-247.
21. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
22. Solano C, Self MJ, Cobcroft G. Liver transplant acquired activated protein C resistance presenting with deep vein thrombosis 4 years after transplant. Blood Coagul Fibrinolysis 2001;12:325-326.
23. Parker J, Pagliuca A, Kitiyakara T, Whitehead M, Heaton N, O'Grady J, et al. Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation. Blood 2001;97:2525-2526 (letter).
24. De Mitrio V, Marino R, Rendina M, Di Bari L, Francavilla A, Schiraldi O. Is activated protein C resistance following orthotopic liver transplantation a risk factor for venous thrombosis? Blood Coagul Fibrinolysis 1999;10:211-212 (letter).
25. Gillis S, Lebenthal A, Pogrebijski G, Levy Y, Eldor A, Eid A. Severe thrombotic complications associated with activated protein C resistance acquired by orthotopic liver transplantation. Haemostasis 2000;30:316-320.
26. Hirschfield G, Collier JD, Brown K, Taylor C, Frick T, Baglin TP, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998;4:58-61.
27. Rees DC, Cox M, Cleeg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134.
28. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
29. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231.
30. Mannucci PM. Genetic hypercoagulability: prevention suggests testing family members. Blood 2001;98:21-22.